Company Filing History:
Years Active: 2006-2025
Title: Innovations of Changsheng Liu in Stem Cell Research
Introduction
Changsheng Liu is a prominent inventor based in Shanghai, China, known for his significant contributions to the field of stem cell research. With a total of four patents to his name, Liu has focused on developing innovative solutions for treating hematopoietic damage, which is crucial for patients undergoing therapies such as chemotherapy and radiotherapy.
Latest Patents
Liu's latest patents include groundbreaking technologies that utilize stem cells produced by a stem cell generator. One of his notable inventions is a stem cell generator designed for the generation of organoids after the implantation of biological materials loaded with active substances. These active substances include mesenchymal stem cells and various growth factors that promote bone regeneration. This technology aims to treat conditions such as bone marrow failure and leukemia, which can arise from cancer treatments. Another significant patent involves the use of a fusion protein in drugs that stimulate the differentiation of bone marrow mesenchymal stem cells into hematopoietic stem/progenitor cells. This innovation is intended for the prevention and treatment of hematopoietic dysfunction and leukopenia caused by chemotherapy and radiotherapy.
Career Highlights
Changsheng Liu is affiliated with the East China University of Science and Technology, where he continues to advance his research in stem cell technology. His work has garnered attention for its potential to improve patient outcomes in hematological disorders.
Collaborations
Liu collaborates with esteemed colleagues, including Jing Wang and Yuan Yuan, who contribute to his research endeavors and help in the development of innovative solutions in the field.
Conclusion
Changsheng Liu's contributions to stem cell research exemplify the potential of innovative technologies in medicine. His patents reflect a commitment to addressing critical health challenges and improving treatment options for patients worldwide.